Clinical courses and outcomes of patients with IPS after allogeneic HSCT
. | Conventional; n = 77 . | Nonmyeloablative; n = 4 . |
|---|---|---|
| Time to IPS onset after HSCT, d, median (range) | 22 (4-106) | 16 (7-34) |
| Survival to 30 days after discharge, no. patients (%) | 20 (26) | 1 (25) |
| Time to death after IPS, d, median (range) | 14 (1-979) | 15 (4-279) |
| MV initiated, no. patients (%) | 48 (62) | 2 (50) |
| Time to MV after IPS, d, median (range) | 1 (0-57) | 2 (0-3) |
| Mortality after MV, no. patients (%) | 46 (96) | 2 (100) |
| Time to death after MV, d, median (range) | 7 (1-32) | 11 (4-17) |
. | Conventional; n = 77 . | Nonmyeloablative; n = 4 . |
|---|---|---|
| Time to IPS onset after HSCT, d, median (range) | 22 (4-106) | 16 (7-34) |
| Survival to 30 days after discharge, no. patients (%) | 20 (26) | 1 (25) |
| Time to death after IPS, d, median (range) | 14 (1-979) | 15 (4-279) |
| MV initiated, no. patients (%) | 48 (62) | 2 (50) |
| Time to MV after IPS, d, median (range) | 1 (0-57) | 2 (0-3) |
| Mortality after MV, no. patients (%) | 46 (96) | 2 (100) |
| Time to death after MV, d, median (range) | 7 (1-32) | 11 (4-17) |
Time to death after IPS (n = 70); time to MV after IPS (n = 50); and time to death after MV (n = 48). MV indicates mechanical ventilation.